C-peptide vs hBD-1
Head-to-head comparison of C-peptide (Connecting peptide (C-peptide)) and hBD-1 (Human beta-defensin 1) — benefits, dosing, side effects, research data, and where to buy.
| Property | C-peptide | hBD-1 |
|---|---|---|
| Category | Pain Management | Dental & Oral |
| Full Name | Connecting peptide (C-peptide) | Human beta-defensin 1 |
| Molecular Weight | 3020.3 Da | 4490 Da |
| Half-Life | ~20-30 min | minutes to hours |
| Amino Acids | 31 | 36 |
| Typical Dose | no approved analgesic dose|research-only | 1-10 µg/mL in experimental studies |
| Route | IV|subQ | Topical/Intraoral |
| Purity | ≥98% | ≥98% |
| Studies Count | 46 | 85 |
| Research Status | Pre-clinical | Pre-clinical |
C-peptide Benefits
- ✓diabetic neuropathy research
- ✓nerve function support
- ✓possible analgesic effect
hBD-1 Benefits
- ✓oral innate immunity
- ✓broad antimicrobial activity
- ✓biofilm suppression
- ✓periodontal support
C-peptide Dosing
0.5-1.0 mg/day in research|route varies by protocol
hBD-1 Dosing
topical peptide exposure|cell-culture or mucosal models|repeat low-dose application in research
C-peptide Side Effects
- ⚠injection-site reactions
- ⚠unknown long-term safety
hBD-1 Side Effects
- ⚠protease degradation
- ⚠local irritation at high dose
- ⚠limited stability in saliva
Research Overview
C-peptide
C-peptide is not an approved analgesic, but multiple studies have examined its effects on peripheral nerve blood flow and neuropathy outcomes. The strongest relevance is in diabetic neuropathic pain rather than migraine.
hBD-1
hBD-1 has been studied as part of the oral mucosal defense system and is linked to host resistance against dental pathogens. Research spans periodontitis, candidiasis, and epithelial barrier biology.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.